The overexpression of PD-L1 in cancers such as gastric carcinoma, hepatocellular carcinoma, renal-cell carcinoma, esophageal carcinoma, pancreatic cancer, ovarian cancer, and bladder cancers is associated with poor clinical outcomes, and the detection of its levels has important clinical significance 1. The gene discussed is CD274; the disease is renal cell carcinoma.